(Q47911230)
Statements
1 reference
Aflibercept, bevacizumab or ranibizumab for diabetic macular oedema: recent clinically relevant findings from DRCR.net Protocol T. (English)
1 reference
Sophie Cai
1 reference
Neil M Bressler
1 reference
23 August 2017
1 reference
28
1 reference
6
1 reference
636-643
1 reference
Identifiers
1 reference
1 reference